Promising results for Nano Covax vaccine in phase 3a of clinical trials
A local research team working on developing Nano Covax, a homegrown COVID-19 vaccine, have unveiled the promising outcomes of the mid-term phase 3a clinical trials.
A local research team working on developing Nano Covax, a homegrown COVID-19 vaccine, have unveiled the promising outcomes of the mid-term phase 3a clinical trials.